Clinical Guidelines
From the Journals
AAO Updates HCQ Retinopathy Guidance
Updated recommendations emphasize dosing limits and screening for toxicity risk.
Updated guidelines from the American Academy of Ophthalmology suggest that the risk of hydroxychloroquine (HCQ) retinopathy is low when appropriate doses are maintained and regular screening is implemented. The revised guidance integrates advancements in retinal imaging and artificial intelligence to enhance screening recommendations for long-term HCQ users, primarily women with systemic lupus erythematosus and rheumatoid arthritis. Key recommendations include utilizing optical coherence tomography (OCT) and fundus autofluorescence (FAF) for baseline assessments and ongoing monitoring.
